• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种将镰状细胞血红蛋白病与肾髓质癌中 SMARCB1 缺失联系起来的模型。

A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.

机构信息

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Center for Precision Environmental Health, Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, Texas.

出版信息

Clin Cancer Res. 2018 May 1;24(9):2044-2049. doi: 10.1158/1078-0432.CCR-17-3296. Epub 2018 Feb 12.

DOI:10.1158/1078-0432.CCR-17-3296
PMID:29440190
Abstract

Renal medullary carcinoma (RMC) is a highly aggressive malignancy that predominantly afflicts young adults and adolescents with sickle hemoglobinopathies. It is characterized by complete loss of expression of the chromatin remodeler and tumor suppressor Despite therapy, the outcomes of patients with RMC remain very poor, highlighting the need to understand the etiology of this cancer, and develop new diagnostic, preventive, and therapeutic strategies. A key knowledge gap in RMC biology is why sickle hemoglobinopathies predispose to the development of this cancer. We propose a model wherein the extreme conditions of hypoxia and hypertonicity of the renal medulla, combined with regional ischemia induced by red blood cell sickling, activate DNA repair mechanisms to drive deletions and translocations in , which is localized in a fragile region of chromosome 22. This mechanism would explain the linkage between RMC and sickle hemoglobinopathies, as well as the age dependence and predilection of RMC toward the right kidney. This perspective proposes an integrated and testable model of renal medullary carcinoma pathogenesis. Insights provided by this model can additionally inform other malignancies arising from the renal medulla and/or associated with loss of the tumor suppressor gene. .

摘要

肾髓质癌(RMC)是一种高度侵袭性的恶性肿瘤,主要影响患有镰状血红蛋白病的年轻成年人和青少年。它的特征是染色质重塑剂和肿瘤抑制因子的完全缺失。尽管进行了治疗,但 RMC 患者的预后仍然非常差,这凸显了需要了解这种癌症的病因,并开发新的诊断、预防和治疗策略。RMC 生物学中的一个关键知识空白是为什么镰状血红蛋白病易导致这种癌症的发生。我们提出了一个模型,即在肾脏髓质的极端缺氧和高渗条件下,加上由红细胞镰状化引起的局部缺血,激活 DNA 修复机制,导致 缺失和易位,而 位于染色体 22 的一个脆弱区域。这种机制可以解释 RMC 与镰状血红蛋白病之间的联系,以及 RMC 对右肾的年龄依赖性和偏好性。这种观点提出了一个综合的、可测试的肾髓质癌发病机制模型。该模型提供的见解还可以为其他源自肾脏髓质和/或与 肿瘤抑制基因缺失相关的恶性肿瘤提供信息。

相似文献

1
A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.一种将镰状细胞血红蛋白病与肾髓质癌中 SMARCB1 缺失联系起来的模型。
Clin Cancer Res. 2018 May 1;24(9):2044-2049. doi: 10.1158/1078-0432.CCR-17-3296. Epub 2018 Feb 12.
2
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.CA-125作为肾髓质癌的生物标志物:综合分子剖析、功能特征及前瞻性临床验证
Clin Cancer Res. 2025 Mar 17;31(6):1057-1068. doi: 10.1158/1078-0432.CCR-24-3324.
3
SMARCB1-deficient Medullary-Like Renal Cell Carcinoma Without Gene Deletion.无基因缺失的SMARCB1缺陷型髓样肾细胞癌
Int J Surg Pathol. 2025 Sep;33(6):1499-1504. doi: 10.1177/10668969251316906. Epub 2025 Feb 21.
4
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
5
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
6
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.血管紧张素转换酶(ACE)抑制剂治疗镰状细胞病患者的蛋白尿和微量白蛋白尿。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD009191. doi: 10.1002/14651858.CD009191.pub4.
7
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
8
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis.肾髓质癌脑转移中胶质细胞转分化的一例新病例。
Acta Neuropathol Commun. 2025 Jan 20;13(1):12. doi: 10.1186/s40478-025-01929-w.
9
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
10
Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.血管紧张素转换酶(ACE)抑制剂用于镰状细胞病患者的蛋白尿和微量白蛋白尿。
Cochrane Database Syst Rev. 2015 Jun 4;2015(6):CD009191. doi: 10.1002/14651858.CD009191.pub3.

引用本文的文献

1
Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma.病例报告:一名患有转移性SMARCB1缺陷型肾髓质癌的孕妇化疗后成功分娩。
Front Oncol. 2025 Aug 29;15:1606647. doi: 10.3389/fonc.2025.1606647. eCollection 2025.
2
Unclassifiable renal carcinoma with medullary phenotype and SMARCB1 deficiency: case report.具有髓质表型和SMARCB1缺陷的不可分类肾癌:病例报告
Front Urol. 2025 Jun 6;5:1582675. doi: 10.3389/fruro.2025.1582675. eCollection 2025.
3
Methylation profile of individuals with sickle cell trait.

本文引用的文献

1
Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.肾细胞癌,未分类,具有髓样表型:与肾髓样癌重叠的低分化腺癌。
Hum Pathol. 2017 Sep;67:134-145. doi: 10.1016/j.humpath.2017.07.006. Epub 2017 Jul 15.
2
Renal Medullary Carcinoma: Establishing Standards in Practice.肾髓质癌:确立实践标准
J Oncol Pract. 2017 Jul;13(7):414-421. doi: 10.1200/JOP.2017.020909.
3
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.
具有镰状细胞性状个体的甲基化谱。
Epigenetics. 2025 Dec;20(1):2539234. doi: 10.1080/15592294.2025.2539234. Epub 2025 Aug 4.
4
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma.剧烈体育活动作为肾髓质癌的一种潜在环境危险因素。
Urol Oncol. 2025 Jul 4. doi: 10.1016/j.urolonc.2025.06.012.
5
Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.贝伐单抗和厄洛替尼在肾髓质癌和富马酸水合酶缺乏性肾细胞癌临床前模型中的疗效差异
Mol Cancer Ther. 2025 Jul 2. doi: 10.1158/1535-7163.MCT-24-0703.
6
Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategies.非透明细胞肾细胞癌的最新进展:生物学与治疗策略
Ther Adv Med Oncol. 2025 Jun 16;17:17588359251345722. doi: 10.1177/17588359251345722. eCollection 2025.
7
Sickle cell disease induces chromatin introversion and ferroptosis in CD8 T cells to suppress anti-tumor immunity.镰状细胞病诱导CD8 T细胞中的染色质内陷和铁死亡以抑制抗肿瘤免疫。
Immunity. 2025 Jun 10;58(6):1484-1501.e11. doi: 10.1016/j.immuni.2025.04.020. Epub 2025 May 12.
8
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.运用机器学习影像组学方法鉴别肾髓质癌和透明细胞肾细胞癌。
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae337.
9
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.儿童非肾母细胞瘤性肾癌生物学的标志性发现。
Nat Rev Urol. 2025 Jan 29. doi: 10.1038/s41585-024-00993-6.
10
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.CA-125作为肾髓质癌的生物标志物:综合分子剖析、功能特征及前瞻性临床验证
Clin Cancer Res. 2025 Mar 17;31(6):1057-1068. doi: 10.1158/1078-0432.CCR-24-3324.
核心非同源末端连接因子在致癌作用和癌症中的作用
Cancers (Basel). 2017 Jul 6;9(7):81. doi: 10.3390/cancers9070081.
4
Drugging the Cancers Addicted to DNA Repair.对依赖DNA修复的癌症进行药物治疗。
J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx059.
5
Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.集合管癌及相关肾细胞癌的临床病理与分子病理学
Adv Anat Pathol. 2017 Mar;24(2):65-77. doi: 10.1097/PAP.0000000000000138.
6
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.肾髓质癌患者的管理与预后:一项多中心协作研究。
BJU Int. 2017 Dec;120(6):782-792. doi: 10.1111/bju.13705. Epub 2016 Dec 9.
7
Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.肾髓质癌是镰状细胞病的第七种肾病吗?一项尼日利亚多中心调查。
Afr Health Sci. 2016 Jun;16(2):490-6. doi: 10.4314/ahs.v16i2.17.
8
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.BAF(mSWI/SNF)和PBAF复合物在癌症中的多种作用
Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a026930. doi: 10.1101/cshperspect.a026930.
9
The Philadelphia chromosome in leukemogenesis.白血病发生中的费城染色体。
Chin J Cancer. 2016 May 27;35:48. doi: 10.1186/s40880-016-0108-0.
10
22q11.2 deletion syndrome.22q11.2 缺失综合征。
Nat Rev Dis Primers. 2015 Nov 19;1:15071. doi: 10.1038/nrdp.2015.71.